Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-001170

EVP, GM Cell Therapy sold 24,890 shares at $4.55 ($113,250)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Groot Eleanor EVP, GM Cell Therapy 2020-01-02 Sale −24,890 $4.55 $113,250 174,333 D
Open-market sales · 24,890 sh · avg $4.55 · $113,250
Loading xslF345X03/doc4.xml…